CP-212 Effectiveness and safety of new direct acting antivirals for the treatment of hepatitis C inf...
CP-212 Effectiveness and safety of new direct acting antivirals for the treatment of hepatitis C infection: Preliminary data in a coinfected HIV/HCV population
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundIn 2015, the development of well tolerated and highly effective direct acting antivirals (DAAs) for hepatitis C virus (HCV) dramatically changed the therapeutic landscape. However, data are lacking on the effectiveness and safety of these combinations in patients coinfected with human immunodeficiency virus type 1(HIV-1).PurposeTo provide...
Alternative Titles
Full title
CP-212 Effectiveness and safety of new direct acting antivirals for the treatment of hepatitis C infection: Preliminary data in a coinfected HIV/HCV population
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2552749218
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552749218
Other Identifiers
ISSN
2047-9956
E-ISSN
2047-9964
DOI
10.1136/ejhpharm-2016-000875.212
